Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.2.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 145,695 $ 62,632
Equity method investments 3,371,373 2,966,305
Receivables, net of allowance of $48 million and $50 million, respectively 2,768,790 3,073,855
Receivables held-for-sale 36,383 35,299
Real estate 2,990 111,036
Investments 7,065 7,165
Securitization assets, net of allowance of $3 million and $3 million, respectively 237,865 218,946
Other assets 88,581 77,112
Total Assets 6,658,742 6,552,350
Liabilities:    
Accounts payable, accrued expenses and other 222,297 163,305
Credit facilities 316,589 400,861
Commercial paper notes 110,326 30,196
Term loans payable 414,117 727,458
Senior unsecured notes 2,523,638 2,318,841
Convertible notes 614,412 609,608
Total Liabilities 4,335,575 4,410,725
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 115,151,661 and 112,174,279 shares issued and outstanding, respectively 1,152 1,122
Additional paid-in capital 2,467,512 2,381,510
Accumulated deficit (249,277) (303,536)
Accumulated other comprehensive income (loss) 41,052 13,165
Non-controlling interest 62,728 49,364
Total Stockholders’ Equity 2,323,167 2,141,625
Total Liabilities and Stockholders’ Equity 6,658,742 6,552,350
Non-recourse debt    
Liabilities:    
Non-recourse debt (secured by assets of $306 million and $239 million, respectively) $ 134,196 $ 160,456